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ABSTRACT: This study aims to prove that papaya seed extract has the potential to improve muscle cell 
atrophy in diabetic conditions. Type 2 diabetes mellitus (DM) animal model were made with conditions 
similar to type 2 DM in humans i.e. with long-term (56 days) high sugar (fructose) consumption. Then, 
the next 14 days were treated with papaya seed extract at the dose of 100, 200, and 300 mg/kg BW 
orally. Body weight and blood glucose levels were monitored throughout the study period. At the end of 
the study, histopathological examination of gastrocnemius skeletal muscle tissue was carried out using 
hematoxylin-eosin staining and measuring myocyte cell area. Results showed that there is a correlation 
between blood glucose levels with the area of muscle cells which explains that the decrease in blood 
glucose levels is in line with the increase in the area of muscle fiber cells. In the diabetic group and the 
treatment group the dose of 100 mg/kg BW has a smaller area, whereas in the treatment group the 
dose of 200 and 300 mg/kg BW has an area close to the area of the muscle cell in the normal group. 
This is supported by the results of measurements of the area of muscle fiber cells observed through cross 
sections and measured at the end of this study. The treatment group at the dose of 200 and 300 mg/kg 
BW did not have significant difference (P>0.05) compared to the normal group. It can be concluded that 
papaya seed extract therapy at the dose of 200 and 300 mg/kg BW on diabetic rats can reduce the fasting 
blood glucose levels so that it can ameliorate cell atrophy in the diabetic conditions.
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1. Introduction 
The development of health in Indonesia is in-creasing, as evidenced by more and more health innovations to improve public health. Although its development is quite rapid, Indonesia has health problems that are still a burden and a ma-jor challenge in the world of health. NCD World Health Organization (WHO) reports that 60% of the causes of death in the world are Non-Commu-nicable Diseases (NCD). Diabetes mellitus (DM) is 6th rank as a cause of death. WHO predicts an increase in the number of DM in Indonesia from 8.4 million people in 2000 increased 2-3 times to around 21.3 million in 2030. Whereas the Inter-national Diabetes Federation (IDF) predicts an increase in the number of people with DM in In-donesia, from 9.1 million people in 2014 to 14.1 million in 2030. Diabetes mellitus is a disease that can reduce the quality of human resources and have big impact on increasing of health costs. Therefore, management of DM requires the par-ticipation of both health workers such as doctors, pharmacists, as well as nurses and the patient’s family in order to better understand the healthy lifestyle, prevention and management of DM. A good understanding will help improve efforts to manage DM in order to achieve better results [1].  Diabetes mellitus is caused by heterogeneous clinical and genetic disorders, marked by hyper-
glycemia due to insulin function insufficiency [2]. Type 2 diabetes is characterized by impaired insulin action or abnormal insulin secretion. Ab-normalities that occur in type 2 DM are insulin resistance where the insulin condition is unable to provide biological effects in the circulation at effective concentrations in normal subjects. In-sulin resistance is a factor associated with meta-bolic syndrome including glucose intolerance, hy-pertension and dyslipidemia. Insulin resistance triggers decreased glucose uptake and glycogen synthesis in peripheral tissues. Disorders of gly-cogen storage in the liver and glycogen synthase activity are also related to the presence of insulin resistance. Resistance that occurs in the antili-
polytic action of insulin affects the breakdown of triglycerides in adipose tissue and the formation of free fatty acids that can inhibit the action of in-sulin to stimulate glucose uptake and metabolism in skeletal muscle and stimulate gluconeogenesis in the liver and disrupt insulin receptor signals. In the initial phase II type DM, resistance to the ac-tion of insulin to reduce blood glucose results in a slight increase in blood glucose concentration, which stimulates insulin secretion and causes hyperinsulinemia. Initially, the condition of hy-perinsulinemia can overcome insulin resistance. But along with the increasing development of the disease, prolonged insulin secretion cannot com-pensate for insulin resistance so that in fasting conditions and after eating hyperglycemia will occur [3].Diabetes is associated with loss of muscle mass and strength as we age. Low muscle mass and poor muscle strength cause functional disor-ders in DM patient, especially in the elderly who are often known as sarcopenia. The incidence of sarcopenia in the elderly accompanied by DM in-creases the risk of functional impairment in some physical activities compared to the elderly with-out DM. Some studies have shown that the condi-tion of glucose intolerance and insulin resistance correlates with muscle mass and strength [4]. Skeletal muscle is a major part that utilizes 80% glucose from the whole body which is stimula–ted by insulin and plays an important role in the pathogenesis of insulin resistance [5]. Skeletal muscle atrophy occurs in a diabetic state and is associated with a direct effect of low serum insu-lin. Morphometric studies describe a reduction in 
the area of muscle fiber cells in a diabetic state [6].Herbal medicines have been developed for the management of type 2 DM. More than 1200 plants are claimed to have antihyperglycemic ac-tivity. 400 types of plants have been studied for the treatment of type 2 DM [7]. Papaya (Carica 
papaya L.) is widely cultivated plant in Indonesia and it is an economically valuable type of plant. Papaya seeds which are considered as waste 
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have several health benefits. Ethnobotany sur-vey shows that papaya seeds are widely used as herbs for the management of several diseases such as stomach discomfort, pain, malaria, dia-betes, obesity, and infection. Papaya seeds are rich 
in proteins, lipids, and fiber. In addition, the poly-phenol content in the form of phenolic acids and 
flavonoids in papaya seeds have high antioxidant activity and anti-hyperglycemia activity. Papaya 
seed extract is thought to reduce the rate of glu-cose absorption in the intestine, increase the use of glucose in the peripheral, stimulate the ability 
of pancreatic β cells to produce insulin or im-
prove pancreatic β cells [8]. Papaya seed extract 
has also been investigated to increase GLUT 4 ex-pression in the skeletal muscle cells of diabetic rats, thereby increasing glucose uptake into cells 
[9]. With increased expression of GLUT 4 in mus-
cle cells it is expected to prevent atrophy.Therefore, to prove that papaya seeds have the potential to improve muscle cell atrophy in dia-betic conditions, this current study was carried 
out by observing changes in the extent of skeletal 
muscle cell fibers in diabetic model rat given pa-
paya seed extract. This study aimed to prove that 
administration of papaya seed extract on diabetic rat can reduce blood glucose levels which corre-late with improvement of cell atrophy.
2. Materials and methods 
2.1. Equipment and materials This study used a blood glucose meter,  UV-Visi-ble spectrophotometer, light microscope (Nikon 
H600L) which is equipped with a 300 megapixel DS Fi2 digital camera and micro–meter software that is encircled by the Nikon Image System. The materials used consisted of papaya seed, demi–
neralized water, fructose solution (20%), xylol, 
alcohol, hematoxylin solution, eosin solution, and diethyl ether.
2.2. Animal handlingThis study used 40 rats (Rattus norwegicus) 
wistar strain with the body weight of 200-300 g. The study design was completely randomized de-sign Posttest control group design. Animals were divided into 4 groups i.e. one negative control group (diabetic) and 3 treatment groups which 
were given papaya seed extract in the dose of 100, 200, and 300 mg/kg BW, respectively. All groups were given normal feed and drink ad libitum. The body weight of animals was weighed at the begin-ning, before and after induction of type 2 DM, and at the end of the study. All animals were adapted for 14 days, then oral fructose solution at a dose of 9 g/kg BW was given on the day of 15 for 56 
days. It was expected to induce type 2 DM. Af-ter 56 days of fructose administration, rats were fasted for 6 hours then blood glucose levels were measured. Rats with blood glucose levels of more than 150 mg/dL were then used in this study as treatment and control groups. Furthermore, the 
treatment group was given papaya seed extract for 14 days while the control group was only gi–ven carrier solvent. On the day of 84, all animals 
were sacrificed, after being fasted 6 hours before. Test animals were anesthetized using diethyl ether by inhalation. The rat is then dissected from the abdomen using a scalpel until the heart is visible. Furthermore, intracardiac blood is taken using a 23 G needle with a 5 ml syringe. Blood samples were subsequent used to analyze blood glucose levels by enzymatic methods using a spectro-photometer. Intake of skeletal muscle tissue was carried out in the gastrocnemius portion of each group of rats at the end of the study. The tissue 
is then fixed with 10% formalin neutral buffer 
for histological analysis using Hematoxylin-Eosin staining.
2.3. Preparation of papaya seed extractRipe papaya fruits were cut into 2 parts, then the seeds were taken and washed twice with tap water. The seeds were then dried at room tempe–rature for 4 weeks and ground using a blender. 500 g of papaya seed powder was macerated 
with 70% alcohol for approximately 3 days, then 
filtered using white cotton cloth and a Buchner 
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funnel. The extract was then evaporated at 40oC 
to produce a thick, sweet-smelling brown extract. 
The extraction process was repeated four times and the resulted solid powder was weighed and stored in an airtight container, then put in a re-frigerator (4oC).
2.4. Gastrocnemius muscle histopathological exa–
mination
This examination aimed to determine the area (µm2) of myocyte cells in rat. Data on myocyte cell area was obtained by calculating the average area 
of five myocyte cells selected from five different 
areas at 400x magnification. The entire examina-tion used a Nikon H600L ordinary light micro-
scope which is equipped with a 300-megapixel DS Fi2 digital camera and a micrometer-encased Nikkon Image System software.
2.5. Data analysisData in each group was analyzed with the Kol-mogorov-smirnov test to determine the norma–lity of data distribution. Data were then analyzed 
using one way ANOVA (α = 0.05). All statistical analysis were conducted using SPSS 20.0 for win-dows.
3. Results and discussion 
This study uses a model approach to type 2 DM that resembles humans. Fructose was used as a type 2 DM inducing compound with the conside–ration that fructose is able to trigger insulin re-sistance. Previous studies suggested that subjects who were given fructose for 10 weeks, would 
experience an increase in body weight of about 
1-3 kg accompanied by a significant increase in instantaneous sugar levels and insulin levels [10]. The body weight of animal (Table 1) was mea-sured at the beginning of the study to determine the inclusion criteria and evaluated during the acclimatization period. Weight loss of more than 10% is a consideration not to be used in this study. During the diabetes induction period and 
treatment, the body weight of animals was moni-tored to determine the dose of fructose solution 
and papaya seed extract as well as to evaluate the occurrence of hyperglycemia conditions.Table 1 shows that body weight at the begin-ning and at the end of the study in all groups of 
animals were not significantly different. Simi-larly, fasting blood glucose level at the beginning 
of the study were not significantly different at all 
groups. However, it was significantly different at the end of the study. Treatment groups showed a decrease in blood glucose levels, especially the 
group treated with papaya seed extract at the dose of 300 mg/kg BW. The fasting blood glucose levels in the negative control and group treated 
with papaya seed extract at the dose of 300 mg/kg BW were 190.17 and 136.83 mg/dL, respec-tively.  A decrease in fasting blood glucose level is followed by an improvement in the area of muscle 
fibers observed through cross sections and mea-sured at the end of the study, as shown in Figure 
1. It exhibited that the decrease in blood glucose levels is proportional to the increase in the area 
of muscle fiber cells (Figure 2).Other studies have shown that fructose admi–nistration was able to decrease insulin sensiti–vity [11]. This was reinforced by a study in healthy 
people which showed a significant decrease in 
the Hepatic Insulin Sensitivity Index (HISI) after administration of fructose in various concentra-tions. Decreased sensitivity to insulin is strongly 
influenced by the dose of fructose entering the 
body. The greater dose will result in a significant decrease in insulin sensitivity [12]. Fructose was used as an inducer of type 2 DM given at a dose of 9 g/kg BW. This dose is capable of causing insulin resistance through the de novo lipogenesis pro-
cess. The formation of fatty acids from excessive de novo lipogenesis can reduce insulin sensitivity, causing a decrease in glucose uptake by insulin-sensitive tissue [13]. One protein on the cell sur-face playing an important role in the process of glucose uptake is GLUT4. Prolonged fructose in-duction can cause desensitization and downregu-lation of insulin receptors so that it can interfere 
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Tabel 1.  Body weight and fasting blood glucose level in the diabetic and the treatment rat group at the 
initial and final of study
with intracellular GLUT4 translocation into the plasma membrane of skeletal muscle cells which subsequently causes a decrease in glucose uptake by insulin-sensitive tissues such as skeletal mus-cles, causing hyperglycemia conditions [9,14]. In this study, the results showed that in hyper-
glycemic conditions, the area of skeletal muscle cells in rat gastrocnemius was smaller (Figure 3b) than those of normal rat (Figure 3a). In this case it is known as cell atrophy. This can be caused by decrease of glucose uptake, a source of ener–gy for cell metabolism. The process of skeletal 
Animal 
Body weight (g) Fasting blood glucose level (mg/dL)  
Initial  Final Initial  Final 
Diabetic Rat 
ͳ ͳͺͺ ʹ͹͸ ͳͳͷ ʹͶͲ
ʹ ͳͻʹ ʹ͹͹ ͳͲͻ ʹͲͶ
͵ ʹͲ͹ ͵ʹ͵ ͳͳ͵ ʹͳ͹
Ͷ ʹʹͲ ͵͵͹ ͻͷ ͳͷͻ
ͷ ͳͺͷ ʹͻͳ ͳͲͶ ͳ͸Ͷ
͸ ͳͻͻ ͵͵Ͳ ͳʹ͵ ͳͷ͹
ά ͳͻͻάͳ͵ ͵Ͳ͸άʹͺ ͳͳͲάͳͲ ͳͻͲά͵ͷ
CPs (100 mg/kg BW)
ͳ ʹ͵ʹ ͵͵ʹ ͳͲͶ ͳ͵ͷ
ʹ ʹʹͻ ͵Ͳʹ ͻ͸ ͳ͸͸
͵ ͳͻͲ ʹͺͲ ͳͳ͵ ͳ͹ͻ
Ͷ ͳͻ͹ ʹ͹ʹ ͳͲ͸ ͳ͵ͺ
ͷ ʹʹͶ ͵ͳ͸ ͳͲͻ ͳͷ͹
͸ ͳͺͲ ʹʹ͵ ͳͳ͹ ͳͷʹ
ά ʹͲͻάʹʹ ʹͺͺά͵ͻ ͳͲͺά͹ ͳͷͷάͳ͹
CPs (200 mg/kg BW)
ͳ ʹͳ͹ ͵͸ͷ ͻͶ ͳͺͲ
ʹ ʹͲʹ ʹͷͻ ͳͲ͹ ͳͳʹ
͵ ͳ͸ʹ ʹͻ͹ ͳͲ͸ ͳ͸Ͷ
Ͷ ͳ͹ͺ ʹ͸Ͳ ͻ͵ ͳ͵͵
ͷ ͳ͸ͺ ʹ͵Ͷ ͳʹͶ ͳʹ͹
͸ ͳͻͷ ʹ͵͹ ͳͲͺ ͳ͸͹
ά ͳͺ͹άʹͳ ʹ͹ͷάͶͻ ͳͲͷάͳͳ ͳͶ͹άʹ͹
CPs (300 mg/kg BW)
ͳ ͳ͹ʹ ͵͵͹ ͳͲͺ ͳ͵ͷ
ʹ ʹͳʹ ͵ʹ͹ ͳͲͻ ͳʹͶ
͵ ʹͲʹ ͵͵Ͳ ͳ͵Ͳ ͳͶ͹
Ͷ ͳͻͺ ʹ͹ͷ ͻ͹ ͳʹͲ
ͷ ʹͲͷ ʹͶͻ ͳ͵Ͷ ͳ͵ͻ
͸ ͳ͸ͺ ʹͻͳ ͳʹͲ ͳͷ͸
ά ͳͻ͵άͳͺ ͵Ͳʹά͵ͷ ͳͳ͸άͳͶ ͳ͵͹άͳͶ
P value ͲǤʹ͹ʹ ͲǤͷʹ͵ ͲǤ͵ͷ͹ ͲǤͲͲ͹
ǣCarica papaya

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Figure 1. The relationship between papaya seed extract dose with the blood glucose levels in diabetic rat
             
             
         
Figure 2. The relationship between papaya seed extract dose with the area of skeletal muscle cells in diabetic ratmuscle cell atrophy can be caused by a decrease in the amount of insulin and involves several mechanisms including disruption of metabolic processes, changes in blood vessels, degenera-tion of motor end plates and damage to myocyte protein synthesis [6]. Decreased insulin response in hyperglycemia condition can also be caused by mTOR inhibition, which causes impaired insulin action on glucose metabolism in skeletal muscle. Insulin resistance can also decrease muscle cell area by suppressing the PI3K-Akt signal pathway, which leads to activation of caspase-3 and pro-teolytic pathways and results in the degradation of muscle protein [15]. Damage to the PI3K-Akt pathway plays a role in reducing insulin-media–
ted glucose uptake and protein synthesis in mice and patients with T2DM [11].Table 2 shows that the area of gastrocnemius 
muscle fibers in cross section in the diabetic and the treatment group (100 mg/kg BW) were sig-
nificantly different from normal group with P values of 0.008 and 0.033, respectively. Other-wise, treatment group with the doses of 200 and 
300 mg/kg BW did not have a significant difference compared to the normal group (P > 0.05). It re-
vealed that the administration of papaya seed ex-
tract was significantly able to ameliorate the area of skeletal muscle cells in diabetic rats approach-
ing normal condition. Papaya seed extract is rich 
in flavonoids and phenolic acid having important 
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Figure 3. Histopathological features of gastrocnemius skeletal muscle with hematoxylin-eosin staining: 
normal rat (a), diabetic rat (b), diabetic rat treated with papaya seed extract at the dose of 100 mg/kg BW (c), 200 mg/kg BW (d), and 300 mg/kg BW (e); arrows indicate cells with atrophy.
Tabel 2.  Cross section of gastrocnemius skeletal muscle cell area of test animal
role as antioxidants and anti-hyperglycemia. Pre-
vious studies have shown that papaya seed ex-
tract can increase GLUT4 expression in hypergly-cemic mice so that it can increase glucose uptake into insulin sensitive tissue [9]. The results of this 
study indicated that papaya extract at a dose of 200 and 300 mg/kg BW were able to improve the atrophy of skeletal muscle cells that occurs in hy-perglycemia conditions.Based on the above data it can be observed that there is a correlation between blood glucose 
levels with the area of muscle cells as shown in 
Figure 1. It explained that the decrease in blood glucose levels is proportional to the increase in 
the area of muscle fiber cells. This can also be seen from the histopathological picture (Figure 2). Diabetic group and the treatment group (100 mg/kg BW) had smaller area, whereas the treat-ment groups (200 and 300 mg/kg BW) had area close to those of the normal group.This research provide insight that Indonesian native plants that have been widely used, papaya, 
No. 





CPs (100 mg/kg 
BW) 
CPs (100 mg/kg 
BW) 
CPs (200 mg/kg 
BW) 
ͳ ͳͻͶͷǤʹ͵ ͻ͵ͷǤ͸ͷ ͻͷʹǤͳͺ ͳͳͶʹǤͺʹ ͳ͵͹ͲǤ͹ͳ 
ʹ ͳ͵ͶͺǤ͵͹ ͻͷ͵Ǥ͵ͷ ͸ͻͻǤ͵ͻ ͻͶͳǤ͹͹ ͳͳͲͲǤͲ͸ 
͵ ͻʹͳǤͲ͸ ͹͸ͶǤ͸͸ ͻͷʹǤͳͺ ͳͳͳͺǤͷͳ ͳ͸ͶͻǤͶͻ 
Ͷ ͳ͸Ͷ͸Ǥͷ ͻͳͲǤ͸͵ ͻ͸͸Ǥͳ͵ ͳͶͶ͵Ǥͳͷ ͳͷͳͷǤͷͻ 
ͷ ͳͶ͵͵ ͻ͹ͲǤ͵Ͳ ͳʹ͹͵Ǥ͸ͻ ͻʹ͹Ǥͳ͹ ͳʹ͹͵Ǥ͸ͺ 
͸ ͳͳ͵ͶǤͷ͵ ͺ͸ͺǤͶͻ ͳͳͲͲǤͲ͹ ͳͲͶʹǤͶͲ ͳ͵ͲͲǤ͸͸ 
ά
 
ͳͶͲͶǤ͹ͺά͵͸͵Ǥ͹͵ ͻͲͲǤͷͳά͹ͷǤͶ͹ ͻͻͲǤ͸ͳάʹͳͳǤ͵͹ ͳͳͲʹǤ͸ͶάͳͺͺǤ͹Ͷ ͳ͵͸ͺǤ͵͹άͳͷͷǤ͵Ͳ 
P value* ͲǤͲͲ͹͹ ͲǤͲ͵ʹͻ ͲǤͳͲͳͲ ͲǤͺ͵ʹͻ 
ȗǢǣCarica papaya
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can improve the muscle cell atrophy in hyper-glycemia condition. It was predicted through its role in improving insulin sensitivity by increasing 
GLUT4 expression and regulating pathways PI3K-Akt signals that are important in the process of glucose uptake in insulin sensitive tissues such as 
muscles. It is hoped that papaya seed extract can be used as a potential alternative therapy in cell atrophy conditions due to type 2 DM.
4. Conclusions 
It can be concluded that papaya seed ex-tract therapy at the dose of 200 and 300 mg/kg BW on diabetic rats can reduce the fas–ting blood glucose levels so that it can ame-liorate cell atrophy in the diabetic conditions. 
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